S&P・Nasdaq 本質的価値 お問い合わせ

Revelation Biosciences, Inc. REVB NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
57/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Revelation Biosciences, Inc. (REVB) has 17 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Fitzpatrick Sean H 1,769,538 株保有. その他の主要保有者には TYPALDOS ANDREAS および GLAZER CAPITAL, LLC.

過去12ヶ月間にインサイダーは 15 件の取引を実施 REVB 株式 — 10 件の買い (評価額 $1.72M) および 0 件の売り (評価額 RSU アワード). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.

REVB インサイダー保有状況

最大保有者
Fitzpatrick Sean H
1,769,538 株
買い(12ヶ月)
10
$1.72M 評価額
売り(12ヶ月)
0
$0.00 評価額
12ヶ月取引活動
買い 67%
売り 0%
インサイダー上位保有者
# 氏名 役職 保有株数 最終申告日 相対規模
1 Fitzpatrick Sean H 10 Percent Owner, Officer: Chief Executive Officer 1,769,538 2020-12-31
100%
2 Typaldos Andreas 10 Percent Owner, Officer: Chief Executive Officer 1,769,538 2020-12-31
100%
3 Glazer Capital, Llc 10 Percent Owner 992,652 2021-09-23
56%
4 Feis Lawrence 10 Percent Owner 746,491 2021-11-02
42%
5 Rolke James Chief Executive Officer 224,853 2026-02-05
13%
6 Zygmont Chester Stanley Iii Chief Financial Officer 105,348 2026-02-05
6%
7 Roper Jess Director 12,828 2026-02-05
1%
8 Carver Jennifer Director 12,758 2026-02-05
1%
9 Chawla Lakhmir S Director 12,158 2026-02-05
1%
10 Angelides Kimon Director 10,000 2020-10-09
1%
11 Dobkin David Director 10,000 2020-10-09
1%
12 Dennis Barry Director 10,000 2020-10-09
1%
13 Hayes Anthony Director 10,000 2020-10-09
1%
14 Carson William Howard Director 10,000 2021-03-11
1%
15 Nicholson Robert D Director 10,000 2020-10-09
1%
16 Labelle Curt H Director 6,356 2023-04-18
0%
17 Tidmarsh George F Director 268 2025-02-13
0%
最近の取引 (過去12ヶ月)
日付 氏名 役職 種類 株数 株価 価値
2026-02-04 Zygmont Chester Stanley Iii Chief Financial Officer RSU 源泉徴収 13,100 $1.65 $21.62K
2026-02-03 Rolke James Chief Executive Officer RSU 源泉徴収 8,521 $1.86 $15.85K
2026-02-03 Carver Jennifer Director RSU 源泉徴収 1,661 $1.87 $3.11K
2026-02-03 Chawla Lakhmir S Director RSU 源泉徴収 2,261 $1.85 $4.18K
2026-02-03 Roper Jess Director RSU 源泉徴収 1,591 $1.85 $2.94K
2026-01-08 Zygmont Chester Stanley Iii Chief Financial Officer RSU 付与(制限付株式) 78,145 $0.90 $70.33K
2026-01-08 Rolke James Chief Executive Officer RSU 付与(制限付株式) 532,829 $0.90 $479.55K
2026-01-08 Carver Jennifer Director RSU 付与(制限付株式) 41,981 $0.90 $37.78K
2026-01-08 Chawla Lakhmir S Director RSU 付与(制限付株式) 41,981 $0.90 $37.78K
2026-01-08 Roper Jess Director RSU 付与(制限付株式) 41,981 $0.90 $37.78K
2025-10-29 Zygmont Chester Stanley Iii Chief Financial Officer RSU 付与(制限付株式) 390,614 $1.28 $499.99K
2025-10-29 Rolke James Chief Executive Officer RSU 付与(制限付株式) 390,614 $1.28 $499.99K
2025-10-29 Carver Jennifer Director RSU 付与(制限付株式) 15,625 $1.28 $20K
2025-10-29 Chawla Lakhmir S Director RSU 付与(制限付株式) 15,625 $1.28 $20K
2025-10-29 Roper Jess Director RSU 付与(制限付株式) 15,625 $1.28 $20K
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る